drugset / Trial / NCT01675960

Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children

NCT01675960

Phase 2 Terminated 2 enrolled Gillette Children's Specialty Healthcare
RandomizedCrossoverTriple-blindTreatment

Summary

This study is a prospective, randomized, double blind, placebo controlled, crossover clinical trial looking at whether gabapentin can provide symptom relief for chronic irritability in neurologically impaired children. The investigators hypothesize gabapentin ins beneficial and safe for children with chronic irritability that persists despite identification and appropriate management of symptom sources.

Timeline

Start
2012-04
Primary completion
2017-07
Completion
2017-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 40 mg/kg Oral